PlainPharmaWatch

CMS Open Payments · Program Year 2024

Ipsen Biopharmaceuticals, Inc

Ipsen Biopharmaceuticals, Inc reported $16,775,240.38 in payments to 20,198 physicians and teaching hospitals across 20,311 transactions.

See the rankings → How this is sourced
$16.8M
Total payments
20,311
Transactions
20,198
Recipients
+$1.9M
General Payments vs PY2023

Ipsen Biopharmaceuticals, Inc reported $16,775,240.38 in payments to 20,198 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #110 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $830.54 per recipient across 7 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Ipsen Biopharmaceuticals, Inc pairs top-10% payment volume with an unusually diversified payment pattern across a wide recipient base.

#110
of 1,925 companies
0.1%
of all US industry payments
0.0%
paid to its single top recipient
7
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Ipsen Biopharmaceuticals, Inc's CMS-reported General Payments increased by $1.9M (+70.7%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: IPSEN BIOPHARMACEUTICALS, INCPY2023: IPSEN BIOPHARMACEUTICALS, INCPY2024: Ipsen Biopharmaceuticals, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$2.6MPY2024$4.5M
PY2023
$2,633,962.24
PY2024
$4,496,612.91

How Ipsen Biopharmaceuticals, Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Ipsen Biopharmaceuticals, Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$16,775,240 Top 6% higher than 94% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). This entry sits in this band. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Ipsen Biopharmaceuticals, Inc

Rank #110 of 1,925 companies in CMS Open Payments for 2024 belongs to Ipsen Biopharmaceuticals, Inc, which reported $16,775,240.38 across 20,311 transactions to 20,198 recipients - representing 0.1% of all industry payments reported nationwide for the year. Averages work out to $825.92 per transaction and $830.54 per recipient.

"Compensation for Services Other Than Consulting" leads the 7-category general-payment breakdown below at $3.0M (17.7% of the company's reported total, 762 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Ipsen Biopharmaceuticals, Inc's 7-category general-payment breakdown at $3.0M, 17.7% of the reported total.

How Ipsen Biopharmaceuticals, Inc divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$3.0M2. Food and Beverage$576.3K3. Travel and Lodging$318.5K4. Space Rental or Facility …$240.3K5. Honoraria$186.2K6. Education$114.8K7. Consulting Fee$92.7K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $3.0M 762
Food and Beverage $576.3K 18,085
Travel and Lodging $318.5K 809
Space Rental or Facility Fees $240.3K 73
Honoraria $186.2K 56
Education $114.8K 383
Consulting Fee $92.7K 30

Recipient Concentration in General Payments

The five largest recipient relationships account for $501,284.01 (11.1%) of $4,496,612.91 in this company's General Payments records across 9,790 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Ipsen Biopharmaceuticals, Inc

The five named recipients with the highest reported General Payments from this company

Monica Verduzco-Gutierrez$113.3KRush University Medical Cent…$103.5KSonal Kumar$96.6KMichael a Morse$95.1KNaim Alkhouri$92.9K
  1. 1

    Monica Verduzco-Gutierrez

    $113,277.28 across 61 reported transactions

  2. 2

    Rush University Medical Center

    $103,457.00 across 2 reported transactions

  3. 3

    Sonal Kumar

    $96,598.80 across 50 reported transactions

  4. 4

    Michael a Morse

    $95,099.38 across 52 reported transactions

  5. 5

    Naim Alkhouri

    $92,851.55 across 43 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $825.92. Average per recipient: $830.54.

Total Amount

$16,775,240.38

Avg per Transaction

$825.92

Avg per Recipient

$830.54

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Ipsen Biopharmaceuticals, Inc Share

0.1%

#110 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Ipsen Biopharmaceuticals, Inc

Seqirus USA Inc

$16.7M 6,517 recipients

Janssen Pharmaceuticals, Inc

$16.8M 169,360 recipients

Vanda Pharmaceuticals Inc.

$16.9M 38,897 recipients

GastroGPO, LLC

$16.6M 8 recipients

Alkermes, Inc.

$16.6M 83,613 recipients

Endotronix, Inc.

$17.0M 179 recipients

Frequently Asked Questions

How much did Ipsen Biopharmaceuticals, Inc pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $16,775,240.38 from Ipsen Biopharmaceuticals, Inc to physicians and hospitals across 20,311 transactions - 0.1% of all industry payments reported that year.
How many physicians received payments from Ipsen Biopharmaceuticals, Inc? ▾
20,198 physicians and teaching hospitals received payments from Ipsen Biopharmaceuticals, Inc in 2024, averaging $830.54 per recipient.
What types of payments did Ipsen Biopharmaceuticals, Inc make? ▾
General payments from Ipsen Biopharmaceuticals, Inc span 7 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $3.0M, representing 17.7% of the company's reported total.
How does Ipsen Biopharmaceuticals, Inc rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Ipsen Biopharmaceuticals, Inc ranks #110 by total payment amount.
What is the average payment size from Ipsen Biopharmaceuticals, Inc? ▾
The average transaction from Ipsen Biopharmaceuticals, Inc was $825.92 in 2024. The company made 20,311 total transactions to 20,198 recipients.
Where does the payment data for Ipsen Biopharmaceuticals, Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Ipsen Biopharmaceuticals, Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.